BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 9288775)

  • 1. CREB-binding protein and p300/CBP-associated factor are transcriptional coactivators of the p53 tumor suppressor protein.
    Scolnick DM; Chehab NH; Stavridi ES; Lien MC; Caruso L; Moran E; Berger SL; Halazonetis TD
    Cancer Res; 1997 Sep; 57(17):3693-6. PubMed ID: 9288775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional interplay between p53 and E2F through co-activator p300.
    Lee CW; Sørensen TS; Shikama N; La Thangue NB
    Oncogene; 1998 May; 16(21):2695-710. PubMed ID: 9652736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of p53-mediated transactivation and cell cycle arrest by E1A through its p300/CBP-interacting region.
    Somasundaram K; El-Deiry WS
    Oncogene; 1997 Mar; 14(9):1047-57. PubMed ID: 9070653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding and modulation of p53 by p300/CBP coactivators.
    Lill NL; Grossman SR; Ginsberg D; DeCaprio J; Livingston DM
    Nature; 1997 Jun; 387(6635):823-7. PubMed ID: 9194565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel transcriptional repression domain mediates p21(WAF1/CIP1) induction of p300 transactivation.
    Snowden AW; Anderson LA; Webster GA; Perkins ND
    Mol Cell Biol; 2000 Apr; 20(8):2676-86. PubMed ID: 10733570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human homologue of yeast Rad23 protein A interacts with p300/cyclic AMP-responsive element binding (CREB)-binding protein to down-regulate transcriptional activity of p53.
    Zhu Q; Wani G; Wani MA; Wani AA
    Cancer Res; 2001 Jan; 61(1):64-70. PubMed ID: 11196199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct roles of the co-activators p300 and CBP in retinoic-acid-induced F9-cell differentiation.
    Kawasaki H; Eckner R; Yao TP; Taira K; Chiu R; Livingston DM; Yokoyama KK
    Nature; 1998 May; 393(6682):284-9. PubMed ID: 9607768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic activation of transcription by CBP and p53.
    Gu W; Shi XL; Roeder RG
    Nature; 1997 Jun; 387(6635):819-23. PubMed ID: 9194564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of the p53 homolog p73 by adenoviral oncogene E1A.
    Das S; El-Deiry WS; Somasundaram K
    J Biol Chem; 2003 May; 278(20):18313-20. PubMed ID: 12639967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of p300, pocket proteins, and hTBP in E1A-mediated transcriptional regulation and inhibition of p53 transactivation activity.
    Sang N; Avantaggiati ML; Giordano A
    J Cell Biochem; 1997 Sep; 66(3):277-85. PubMed ID: 9257185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p300/CBP/p53 interaction and regulation of the p53 response.
    Grossman SR
    Eur J Biochem; 2001 May; 268(10):2773-8. PubMed ID: 11358491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenoviral E1A-associated protein p300 as a functional homologue of the transcriptional co-activator CBP.
    Lundblad JR; Kwok RP; Laurance ME; Harter ML; Goodman RH
    Nature; 1995 Mar; 374(6517):85-8. PubMed ID: 7870179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acetylation of p53 activates transcription through recruitment of coactivators/histone acetyltransferases.
    Barlev NA; Liu L; Chehab NH; Mansfield K; Harris KG; Halazonetis TD; Berger SL
    Mol Cell; 2001 Dec; 8(6):1243-54. PubMed ID: 11779500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smad-dependent stimulation of type I collagen gene expression in human skin fibroblasts by TGF-beta involves functional cooperation with p300/CBP transcriptional coactivators.
    Ghosh AK; Yuan W; Mori Y; Varga J
    Oncogene; 2000 Jul; 19(31):3546-55. PubMed ID: 10918613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional activation by the oestrogen receptor alpha is modulated through inhibition of cyclin-dependent kinases.
    Redeuilh G; Attia A; Mester J; Sabbah M
    Oncogene; 2002 Aug; 21(37):5773-82. PubMed ID: 12173048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human T-cell leukemia virus type 1 Tax activates cyclin-dependent kinase inhibitor p21/Waf1/Cip1 expression through a p53-independent mechanism: Inhibition of cdk2.
    Chowdhury IH; Farhadi A; Wang XF; Robb ML; Birx DL; Kim JH
    Int J Cancer; 2003 Nov; 107(4):603-11. PubMed ID: 14520699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear factor of activated T cells (NFAT)-dependent transactivation regulated by the coactivators p300/CREB-binding protein (CBP).
    García-Rodríguez C; Rao A
    J Exp Med; 1998 Jun; 187(12):2031-6. PubMed ID: 9625762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E6 oncoprotein represses p53-dependent gene activation via inhibition of protein acetylation independently of inducing p53 degradation.
    Thomas MC; Chiang CM
    Mol Cell; 2005 Jan; 17(2):251-64. PubMed ID: 15664194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acetylation of p53 at lysine 373/382 by the histone deacetylase inhibitor depsipeptide induces expression of p21(Waf1/Cip1).
    Zhao Y; Lu S; Wu L; Chai G; Wang H; Chen Y; Sun J; Yu Y; Zhou W; Zheng Q; Wu M; Otterson GA; Zhu WG
    Mol Cell Biol; 2006 Apr; 26(7):2782-90. PubMed ID: 16537920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of an E1A-CBP interaction defines a novel transcriptional adapter motif (TRAM) in CBP/p300.
    O'Connor MJ; Zimmermann H; Nielsen S; Bernard HU; Kouzarides T
    J Virol; 1999 May; 73(5):3574-81. PubMed ID: 10196247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.